Adaptation of the PROFFIT Instrument Into Turkish: A Validity and Reliability Study
ConditionCancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAkdeniz University
About this trial
The aim of this study is to evaluate the Turkish validity and reliability of the Patient Reported Outcomes for Fighting Financial Toxicity of Cancer (PROFFIT) developed in Italy.
Eligibility criteria
Qualifiers
Individuals diagnosed with solid cancer or hematologic malignancy, either histologically or cytologically, and aware of their diagnosis,
Those who have received cancer treatment (chemotherapy, targeted therapy, immunotherapy, hormonal therapy, radiotherapy, or a combination of these treatments) within the last three months,
Individuals over the age of 18,
Those without a diagnosed psychiatric illness (such as depression, panic attacks, schizophrenia, etc.),
Disqualifiers
Individuals who fill out the data collection forms incompletely or wish to withdraw from the study.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Akdeniz University
Lead sponsor
Giresun Training and Research Hospital
Collaborator
St. Mary's University, Twickenham
Collaborator
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Collaborator
Source ClinicalTrials.gov